VALERIE ERICKSON: Open Payments
NPI 1619651452 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 56 payments from 22 companies in 2025. Trend: 2023 $198 · 2024 $1,216 · 2025 $1,293
Food & beverage: $1,178Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $227 |
| ABBVIE INC. | 13 | $194 |
| Vanda Pharmaceuticals Inc. | 5 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Insulet Corporation | 2 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Cala Health, Inc. | 1 | $46 |
| Lilly USA, LLC | 3 | $42 |
Products named: CAPLYTA, SPRAVATO, VRAYLAR, FANAPT, Omnipod, Auvelity, Qelbree, Cala kIQ.
Industry payments across ID — which companies pay providers there.
